1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • San-Juan R, Viedma E, Chaves F, Lalueza A, Fortún J, Loza E, Pujol M, Ardanuy C, Morales I, de Cueto M, Resino-Foz E, Morales-Cartagena A, Rico A, Romero MP, Orellana MÁ, López-Medrano F, Fernández-Ruiz M, Aguado JM.

    High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus

    EMERGING INFECTIOUS DISEASES . 22(6): 1057-1066. Nº de citas: 17

    [doi:10.3201/eid2206.151709]

  • Caniglia EC, Sabin C, Robins JM, Logan R, Cain LE, Abgrall S, Mugavero MJ, Hernandez-Diaz S, Meyer L, Seng R, Drozd DR, Seage GR, Bonnet F, Dabis F, Moore RR, Reiss P, van Sighem A, Mathews WC, Del Amo J, Moreno S, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Napravnik S, Jose S, Phillips A, Olson A, Justice AC, Tate JP, Bucher HC, Egger M, Touloumi G, Sterne JA, Costagliola D, Saag M, Hernán MA, Center for AIDS Research Network of Integrated Clinical Systems and the HIV-CAUS.

    When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study.

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 72(2): 214-221. Nº de citas: 10

    [doi:10.1097/QAI.0000000000000956]

  • Puig-Asensio M, Fernández-Ruiz M, Aguado JM, Merino P, Lora-Pablos D, Guinea J, Martín-Dávila P, Cuenca-Estrella M, Almirante B.

    Propensity Score Analysis of the Role of Initial Antifungal Therapy in the Outcome of Candida glabrata Bloodstream Infections.

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY . 60(6): 3291-3300. Nº de citas: 22

    [doi:10.1128/AAC.00195-16]

  • García-Álvarez L, Sanz MM, Marín M, Fariñas M, Montejo M, Goikoetxea J, Rodríguez García R, de Alarcón A, Almela M, Fernández-Hidalgo N, Alonso Socas MD, Goenaga MÁ, Navas E, Vicioso L, Oteo JA.

    Tropheryma whipplei endocarditis in Spain: Case reports of 17 prospective cases.

    Medicine . 95(26): . Nº de citas: 5

    [doi:10.1097/MD.0000000000004058]

  • Serrano-Villar S, Rojo D, Martínez-Martínez M, Deusch S, Vázquez-Castellanos JF, Bargiela R, Sainz T, Vera M, Moreno S, Estrada V, Gosalbes MJ, Latorre A, Seifert J, Barbas C, Moya A, Ferrer M.

    Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals.

    EBioMedicine . 8: 203-216. Nº de citas: 66

    [doi:10.1016/j.ebiom.2016.04.033]

  • Campos-Varela I, Moreno A, Morbey A, Guaraldi G, Hasson H, Bhamidimarri KR, Castells L, Grewal P, Baños I, Bellot P, Brainard DM, McHutchison JG, Terrault NA.

    Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy.

    ALIMENTARY PHARMACOLOGY & THERAPEUTICS . 43(12): 1319-1329. Nº de citas: 12

    [doi:10.1111/apt.13629]

  • Fortún J, Martín-Dávila P, Gomez Garcia de la Pedrosa E, Silva JT, Garcia-Rodríguez J, Benito D, Venanzi E, Castaño F, Fernández-Ruiz M, Lazaro F, García-Luján R, Quiles I, Cabanillas JJ, Moreno S, Aguado JM.

    Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients.

    JOURNAL OF INFECTION . 72(6): 738-744. Nº de citas: 39

    [doi:10.1016/j.jinf.2016.02.019]

  • Gutiérrez-Gutiérrez B, Bonomo RA, Carmeli Y, Paterson DL, Almirante B, Martínez-Martínez L, Oliver A, Calbo E, Peña C, Akova M, Pitout J, Origüen J, Pintado V, García-Vázquez E, Gasch O, Hamprecht A, Prim N, Tumbarello M, Bou G, Viale P, Tacconelli E, Almela M, Pérez F, Giamarellou H, Cisneros JM, Schwaber MJ, Venditti M, Lowman W, Bermejo J, Hsueh PR, Mora-Rillo M, Gracia-Ahulfinger I, Pascual A, Rodríguez-Baño J, REIPI/ESGBIS/INCREMENT Group.

    Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 71(6): 1672-1680. Nº de citas: 36

    [doi:10.1093/jac/dkv502]

  • Casado JL, Santiuste C, Vazquez M, Bañón S, Rosillo M, Gomez A, Perez-Elías MJ, Caballero C, Rey JM, Moreno S.

    Bone mineral density decline according to renal tubular dysfunction and phosphaturia in tenofovir-exposed HIV-infected patients.

    AIDS . 30(9): 1423-1431. Nº de citas: 41

    [doi:10.1097/QAD.0000000000001067]

  • Gutiérrez C, Serrano-Villar S, Madrid-Elena N, Pérez-Elías MJ, Martín ME, Barbas C, Ruipérez J, Muñoz E, Muñoz-Fernández MA, Castor T, Moreno S.

    Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy.

    AIDS . 30(9): 1385-1392. Nº de citas: 111

    [doi:10.1097/QAD.0000000000001064]

  • Serrano-Villar S, Rojo D, Martínez-Martínez M, Deusch S, Vázquez-Castellanos JF, Sainz T, Vera M, Moreno S, Estrada V, Gosalbes MJ, Latorre A, Margolles A, Seifert J, Barbas C, Moya A, Ferrer M.

    HIV infection results in metabolic alterations in the gut microbiota different from those induced by other diseases.

    SCIENTIFIC REPORTS . 6: 26192-26192. Nº de citas: 32

    [doi:10.1038/srep26192]

  • Norman FF, Monge-Maillo B, Chamorro-Tojeiro S, Pérez-Molina JA, López-Vélez R.

    Imported brucellosis: A case series and literature review.

    TRAVEL MEDICINE AND INFECTIOUS DISEASE . 14(3): 182-199. Nº de citas: 34

    [doi:10.1016/j.tmaid.2016.05.005]

  • Sobrino-Vegas P, Moreno S, Rubio R, Viciana P, Bernardino JI, Blanco JR, Bernal E, Asensi V, Pulido F, Del Amo J, Hernando V, CoRIS.

    Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013.

    JOURNAL OF INFECTION . 72(5): 587-596. Nº de citas: 41

    [doi:10.1016/j.jinf.2016.01.017]

  • Sainz-de-la-Maza S, Casado JL, Pérez-Elías MJ, Moreno A, Quereda C, Moreno S, Corral I.

    Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.

    EUROPEAN JOURNAL OF NEUROLOGY . 23(5): 919-925. Nº de citas: 19

    [doi:10.1111/ene.12963]

  • Martinez-Perez A, Poveda C, Ramírez JD, Norman F, Gironés N, Guhl F, Monge-Maillo B, Fresno M, López-Vélez R.

    Prevalence of Trypanosoma cruzi's Discrete Typing Units in a cohort of Latin American migrants in Spain.

    ACTA TROPICA . 157: 145-150. Nº de citas: 31

    [doi:10.1016/j.actatropica.2016.01.032]

  • Llibre JM, Alvarez H, Antela A, Toro J, Payeras A, Pérez-Elías MJ, Imaz A, Masià M, Pérez-Alvarez N, Burgos J, Clotet B, Members of the Nuke-Out Study.

    Withdrawing inactive NRTIs in HIV-1 subjects with suppressed viraemia: a randomized trial.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 71(5): 1346-1351. Nº de citas: 3

    [doi:10.1093/jac/dkv461]

  • Masiá M, Padilla S, Fernández M, Rodríguez C, Moreno A, Oteo JA, Antela A, Moreno S, Del Amo J, Gutiérrez F, CoRIS, Biobanco.

    Oxidative Stress Predicts All-Cause Mortality in HIV-Infected Patients.

    Plos One . 11(4): . Nº de citas: 32

    [doi:10.1371/journal.pone.0153456]

  • Lambert-Niclot S, George EC, Pozniak A, White E, Schwimmer C, Jessen H, Johnson M, Dunn D, Perno CF, Clotet B, Plettenberg A, Blaxhult A, Palmisano L, Wittkop L, Calvez V, Marcelin AG, Raffi F, NEAT 001/ANRS 143 Study Group.

    Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 71(4): 1056-1062. Nº de citas: 23

    [doi:10.1093/jac/dkv427]